Indian pharmaceuticals policy 2002 reduces number of drugs under price control and opens the market further to foreign investment.
Ribavirin order
This work was supported in part by a Grant-in-Aid for Scientific Research B ; and a Grant-in-Aid for Scientific Research on Priority Areas of ``Channel-Transporter Correlation'' from the Ministry of Education, Science, and Culture of Japan, and by the Mochida Memorial Foundation for Medical and Pharmaceutical Research. Address for reprint requests: K. Inui, Dept. of Pharmacy, Kyoto Univ. Hospital, Sakyo-ku, Kyoto 60601, Japan. Received 24 February 1997; accepted in final form 19 June 1997. REFERENCES 1. Boll, M., M. Herget, M. Wagener, W. M. Weber, D. Markovich, J. Biber, W. Clauss, H. Murer, and H. Daniel. Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. Proc. Natl. Acad. Sci. USA 93: 284289, 1996. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248254, 1976. Daniel, H., and S. A. Adibi. Transport of -lactam antibiotics in kidney brush border membrane. Determinants of their affinity for the oligopeptide H symporter. J. Clin. Invest. 92: 2215 2223, Daniel, H., E. L. Morse, and S. A. Adibi. The high and low affinity transport systems for dipeptides in kidney brush border membrane respond differently to alterations in pH gradient and membrane potential. J. Biol. Chem. 266: 1991719924, 1991. Fei, Y.-J., Y. Kanai, S. Nussberger, V. Ganapathy, F. H. Leibach, M. F. Romero, S. K. Singh, W. F. Boron, and M. A. Hediger. Expression cloning of mammalian proton-coupled oligopeptide transporter. Nature 368: 563566, 1994. Ganapathy, M. E., M. Brandsch, P. D. Prasad, V. Ganapathy, and F. H. Leibach. Differential recognition of -lactam antibiotics by intestinal and renal peptide transporters, PEPT1 and PEPT2. J. Biol. Chem. 270: 2567225677, 1995. Ganapathy, V., and F. H. Leibach. Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit. Studies with L-carnosine and glycyl-L-proline. J. Biol. Chem. 258: 14189 14192, Ganapathy, V., and F. H. Leibach. Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol. 249 Gastrointest. Liver Physiol. 12 ; : G153G160, 1985, for example, ribavirin virazole.
Ribavirin is used in combination with interferon to treat chronic hepatitis c infection.
ATP-binding domain of the enzyme, could increase the affinity of the binding, and consequently, enhance the inhibitory potential of this compound. To test this hypothesis, ribavirin-TP 4 ; was synthesized and employed in inhibition studies.
Have you thought about injectables.
Diabetes complications. A 1% decrease in Hb A1c related to a 37% decrease in risk for microvascular complications and a 21% decrease in the risk of any end point or death related to diabetes.10 Final Hb A1c in the intensive group was 7%, while the conventional group was 7.9%. A similar Japanese study using intensive insulin therapy to prevent the progression of diabetic microvascular complications 11 showed similar results. The Hb A1c reflects glycemic control over the previous 2 to 3 months; therefore, it is recommended to check Hb A1c levels approximately every 3 months. ADA recommends a Hb A1c of less than 7% for glycemic control. It is, however, important to individualize goals. Newer recommendations are more stringent i.e., normal Hb A1c 6% ; and can be considered in individual patients to further reduce cardiovascular risk. Postprandial blood glucose may be targeted if Hb A1c goals are not met despite reaching preprandial glucose goals.6 Table 1 lists a current comparison of the ADA and the American Association of Clinical Endocrinologist AACE ; recommendation for adults with diabetes. AACE Guidelines12 6.5% 110 mg dl 140 mg dl and requip.
With India becoming TRIPS compliant, local companies are looking at drugs going off patent and also the biogenerics market so that they can produce and market the products at an affordable price. During 2002-04, as many as 20 biotech drugs have lost their patents in the US. Of the many drugs, the US patents for 13 biotech products will expire during 2005. Similarly many other blockbuster drugs are expected to lose patent protection over the next few years, paving the way for competitors to legally manufacture biogeneric versions of the biotech products and market them. This represents tremendous potential for biogeneric manufacturers. Since there is no real need to invest in drug discovery and clinical development, biogeneric manufacturers can sell these products at lower prices than the patented original drugs. Companies in developing countries like India are looking at biogenerics as a large number of biologicals are slated to go off patent and the pipeline for potential generic launches is dwindling. Considering this, the market potential for biogenerics will grow significantly in the coming years. According to Frost & Sullivan estimates, the biogenerics markets in Europe and the US alone has the potential to generate sales of $16.4 billion by 2011 at an average annual growth rate of 69.8 percent. The branded biologic products generated an estimated $32 billion of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of drugs. While continued high demand, high prices, and applicability in previously untreatable conditions are behind the success of branded biologics, the absence of generic competition has meant that growth has gone unchallenged. By 2010, biologic products that accrue an estimated $11.2 billion worth of sales annually are expected to lose patent protection in developed pharmaceutical markets. Remicade Chimeric monoclonal antibody; anti-TNF-alpha ; , Epogen Recombinant erythropoietin ; , Enbrel Recombinant fusion protein; soluble TNF receptor linked to IgG1 ; , Aranesp Novel erythropoiesis-stimulating protein 2nd generation EPO , Epogin NeoRecormon Recombinant erythropoietin ; , Neulasta PEGylated version of Neupogen ; Avonex Recombinant interferon beta-1a ; and Pegasys Copegus Recombinant interferon alfa-2a modified with PEG monotherapy; also in combination with Copegus [ribavirin] have recorded sales of $2, 963 million, $2, 891 million, $2, 600 million, $2, 580 million, $2, 500 million, $1, 826 million, $1, 700 million, $1, 417 million and $1, 370 million respectively. This gives an idea about the market potential for these biotech products world over. Companies like Wockhardt, Dr Reddy's Labs and Biocon are looking at entering the regulated market in Europe, which has regulatory system in place for the biogenerics. Wockhardt has received 17 registrations for its biopharmaceuticals and 36 registrations are being pursued in various overseas markets such as Russia, South America, North Africa, Central Asia, South East Asia. It has also formed majority joint ventures in Mexico and South Africa and has set up a subsidiary in Brazil.
Symptoms of hyperthyroidism can include: intolerance to hot weather more frequent bowel movements weight loss despite a good appetite ; tiredness & fatigue anxiety irritability hot, moist velvety skin excessive sweating fine brittle hair muscle weakness especially the upper arms and thighs ; increased heart rate high blood pressure poor concentration fine tremors of the fingers accelerated growth girls may have lighter and less frequent menstrual periods Many people with autoimmune thyroid disease Graves or, in a few cases, Hashimoto's ; develop Thyroid Eye Disease TED ; . This is an autoimmune disease of the orbit eye socket ; and eye muscles, characterised by inflammation, swelling and possible scarring rare occasional ; , with swollen eyelids and "poppy" eyes. TED, however, is usually mild when it occurs in young children. Thyroid nodules are lumps or abnormal growths on the thyroid, whether benign non-cancerous ; or malignant cancerous ; . These are generally asymptomatic, however some people experience tenderness and pain in their thyroid. They can be associated with overactivity, where the person also has symptoms outlined above. Goitre: This is an enlarged thyroid gland. It can sometimes be quite large and uncomfortable. All people suffering from thyroid disorders can develop a goitre. Thyroid cancer: There are different types of thyroid cancer papillary, follicular, anaplastic, medullary, and lymphoma ; , the vast majority of which are readily treatable. How common are they? Hypothyroidism: Hashimoto's thyroiditis is more common in children with a family history of the autoimmune thyroid conditions or other autoimmune conditions. Hypothyroidism affects around 10 boys per 10, 000 and 60 girls per 10, 000. Congenital hypothyroidism affects about one in every 4, 000 births. Hyperthyroidism: Graves' disease is more common in children with a family history of the autoimmune thyroid conditions or other autoimmune conditions. Hyperthyroidism affects around 2 boys per 10, 000, and 4 girls per 10, 000. Thyroid nodules: More common in females than males. However, a nodule in a child or teenager under the age of 20 is more likely to be malignant cancerous ; than a nodule in an adult. Thyroid cancer: In Victoria, for children under 20, there are around 3 new cases of thyroid cancer per year - 1 boy and 2 girls. Thyroid cancer is now recognised with increased frequency in children, adolescents and young adults who have previously been treated with spinal radiation as part of treatment for other different cancers. It is also seen in children who have been exposed to accidental ionising radiation in other countries. All these children should be regularly screened every 2 years with a thyroid ultrasound. Medullary thyroid cancer is an inherited and difficult to treat form of the disease. All family members of a person diagnosed with medullary thyroid cancer should be screened genetically. If this test is positive, the affected person will need to have a preventive thyroidectomy surgical removal of the thyroid gland and ropinirole, for instance, dose of ribavirin.
Ribavirin cardiac side effects
G.04.004.3. The Minister must provide the licensed dealers, pharmacies and licensing authorities who were issued a notice under subsection G.04.004.2 1 ; with a notice of retraction of that notice if a ; b ; the circumstance described in paragraph G.04.004.2 2 ; a ; , the requirements set out in subparagraphs b ; i ; and ii ; have been met and one year has elapsed since the notice was issued by the Minister; or in a circumstance described in any of paragraphs G.04.004.2 2 ; b ; and c ; and 4 ; a ; to the practitioner named in the notice has i ; requested in writing that a retraction of the notice be issued, and ii ; provided a letter from the licensing authority of the province, in which the practitioner is registered or entitled to practise, in which the authority consents to the retraction of the notice.
Table 4. Prescribed daily dose and medication volume ratios and tretinoin.
Tracy Rose, RN, Therasense: Mrs. Rose spoke about the Freestyle glucose meter. Therasense launched the Freestyle meter about three years ago. What makes this meter different from all other meters on the market is the strip technology called kilometry. All other meters use anthrimetric technology. The benefit of kilometry is the measurement of the glucose charge across the strip and within the entire glucose sample. This results in the smallest sample needed. Freestyle is the faster growing meter and the second fastest growing strip in the nation at this time. This means a small puncture wound and less pain. Most patients agree that Freestyle is virtually painless and pain is the greatest reason that patients avoid testing. In addition, patients have a full minute to reapply blood after the first attempt. This equals less wasting of test strips. A second reason to use Freestyle is accuracy. Sampling of Freestyle readings are 98% within target of hospital readings. Many substances interfere with home glucose monitoring such as aspirin, acetominophen, oxygen, and hematocrit. Due to the Freestyle strip technology, glucose readings with Freestyle are not affected by any of these substances. And lastly, Freestyle is a high quality product available at a reasonable and competitive price. Freestyle has recently been chosen one of the preferred providers for MediCal. Bill Moeslein, R.Ph., Bayer Diagnostics: Mr. Moeslein spoke about Bayer Blood Glucose Meters. Bayer was the first company to have a patient blood glucose meter and produced the first blood glucose meter with memory. Their meters are very simple and very convenient, use a very small sample size, are very accurate, and offer alternate site testing on all meters. Bayer provides patient education for diabetic patients that is written on a fifth grade level and the information is also available in multiple languages. One of the great advantages for choosing Bayer as the meter for the Medicaid population is that physicians, health care providers, and pharmacists in West Virginia are very familiar with the Bayer product. Additionally it would mean that health care providers would not have to remember multiple products based on which types of patients that they are seeing. Medicaid would be able to team with the West Virginia Public Employees Insurance Agency, the retail pharmacists, and health care providers to make meters freely available at the site of service. Kevin Lewis, RN, CDE, WVU Pediatrics: Mr. Lewis spoke about growth hormones, blood glucose strips and insulin pens. In reference to growth hormones, Mr. Lewis recommended that the Bureau give at least three to five months of notice because of retraining issues. Each company uses a different device and compliance is going to be a big issue. In reference to blood glucose strips, a three-month notice would be greatly appreciated. Products in his practice are the Accu-Check products, the Bayer products, the Freestyle meter, and the One Touch Ultra from Life Scan. A three to four month turnover time to retrain patients would be very helpful. Although it was not on the agenda, Mr. Lewis stated his concern regarding insulin pens. They are convenient and it is easy to teach a patient how to use them. There are safety issues involved with mixing insulins. It is convenient for the patients to measure the correct dose, inject their dose, and carry the pen in their pockets. It is truly a convenience issue. For the pediatric population, currently pen devices require prior authorization. One of the reasons prior authorization is given is because of the educational setting. Since every one of these.
| Ribavirin formulationMasanori Ikeda and colleagues of Okayama University report the findings in the July issue of the journal Hepatology. "We clearly demonstrated that combination treatment of alpha interferon and [Lescol] was an overwhelmingly more effective treatment, compared with [our] previous results for the combination treatment of alpha interferon with ribavirin, " Ikeda and colleagues conclude. The researchers tested the drugs only in a cell-culture system -- not in people or animals. Also, the concentration of Lescol they found to be effective is about 10 times higher than the concentration seen in the blood of people taking daily 40-milligram doses of the drug Lescol doses as high as 80 milligrams per day are used to lower cholesterol and retrovir.
Immunosuppression prior to live viral vaccinations, at consideration of transplantation and when prescribing immunosuppressant medications. The assessment of HIV risk and subsequent counselling and management of the patient are detailed in Chapters 2, 3 and 8.
The health sector is not only a high risk sector as far as stress and violence is concerned, but also typically a sector with high levels of women present. The exposure to the risks of violence for women is thus consequently particularly high. ILO ICN WHO PSI Joint Programme on Workplace Violence in the Health Sector Working Paper, 2003 and rifater.
|
Bulletin of the world health organization 2004; 82: 381-384, for instance, pegintron ribavirin.
2006; 24 1-2 ; : 207-11 issn: 0257-2753 ; kasper b; kallinowski b; herrmann t; lehnert t; mechtersheimer g; geer t; ho ad; egerer g department of internal medicine v, university of heidelberg, heidelberg, germany and rifampin.
Ribavirin for sars
And exercise with 20% cueing and with ADLs and for energy conservation. Pt. to demonstrate proper use and sequence of MDI's. Pt to identify proper control of environmental triggers, and action plan for worsening PEFR's. Pt to describe proper infection control techniques, cleaning of respiratory equipment and when to seek medical help. To demonstrate 2 secretion clearance techniques. To increase 6 min. walk distance by 20%. To increase UE and LE strength to 4 establish home exercise Rx. To begin and comply with O2 for exercise. To demonstrate correct use of assistive adaptive equipment. To use O2 as Rx'd with proper precautions, because consensus interferon and ribavirin.
The index case of severe acute respiratory syndrome SARS ; 1 was admitted to ward 8A in the Prince of Wales Hospital, Hong Kong, on the March 4, 2003.2 On March 10, 2003, a 33-year-old doctor EBW, figure ; working on ward 8A developed a fever of 396C. He was examined by JJYS. His fever had gone by March 12, and his chest radiograph was normal. His platelet count was 94 109 L and white-cell count was 34 109 L monocytes 04 109 L ; . A nasopharyngeal swab grew no pathogens. He was admitted to the SARS triage ward on March 13, and was started on oseltamivir phosphate 75 mg twice a day and levofloxacin 500 mg daily. Further blood tests showed disseminated intravascular coagulopathy platelets 61 109 L, D-dimer 630 ng mL, prothrombin time 111s, activated partial thromboplastin time APTT ; 433s ; . His white-cell count was 18 109 L neutrophils 11 109 L, lymphocytes 05 109 L, and monocytes 02 109 L. His chest radiograph showed a prominent right hilum. CT of his thorax showed an ill-defined opacity with an air bronchogram in the apical posterior segment of the right lower lobe and diffusely in the right middle lobe. He was started on oral eibavirin 12 g thrice daily and intravenous methylprednisolone 500 mg daily. His fever settled the next morning and his coagulopathy improved APTT 407 s, platelet count 105 109 L, and D-dimer of 564 ng mL ; . March 19, 2003, oral prednisolone 1 mg kg was started. On the evening of March 20, he had a fever of 389C. His white blood cell count rose to 157 109 L predominantly due to an increase in neutrophils ; . A secondary bacterial chest infection was suspected, and cefipime 2 g was given intravenously. Over the next 2 days he became increasingly breathless and his coagulopathy became worse D-dimer 716 ng mL, prothrombin time 119 s, platelets 199 109 L ; . The patient was given a single dose of methylprednisolone 500 mg intravenously and 4 L min of oxygen. After this, he began to get better. Coagulation parameters returned to normal, he was weaned off of oxygen, and was discharged from hospital on March 31, 2003, on 03 mg kg prednisolone and ribavorin 600 mg orally three times a day. On April 7, his chest radiograph showed worsening and risperidone.
One study tested α 2a fixed dose of 180 μ g ; with ribaviriin dose adjusted based on weight 1000 mg for weight < 75 kg, 1200 mg for weight > 75 kg while the other tested α 2b adjusted by weight at 5 μ g kg ; with a fixed dose of ribavirin of 800 mg.
Peginterferon ribavirin therapy
Instilling your values in your child is an important and natural part of child rearing. Make sure your child understands your feelings about her not using drugs. Challenge her to think about her own beliefs and values. Discuss with her the benefits and consequences of the choices she makes and roxithromycin.
Table 1 The effect of optimal concentration of synthetic peptides on serotonin uptake in platelets Peptide: Optimal conc: C.P.M. increase SD N P Percent G-S-E-N 10-10 2408 55 G-S-E-N 10-9 2501 57 G-S-Q-N 10-5 2068 52 G-S-Q-D 10-5 2070 50 Control -1853 54 6.
With more than 9500 drugs on the US market, 9 it makes sense to group drugs into classes or families. Grouping simplifies medical education and clinical practice. Each drug class often is defined by a common mechanism of action. The pharmaceutical industry can freely develop and market late-arriving members of a class, the so-called "me-too" drugs. By forgoing long-term mortality morbidity trials, a company can reduce the costs of drug development, invest in marketing, and offer the unproven drug inexpensively. Because of a smaller financial investment, it can successfully compete with the older and better-documented members on the basis of price. For many policymakers, lower drug cost is an important consideration and reboxetine and ribavirin, for example, mechanism of action of ribavirin.
Polycystic Ovarian Syndrome Association, Inc. 877-775-PCOS : pcosupport International Council on Infertility Information Dissemination 520-544-9548 or 703-379-9178 : inciid The National Women's Health Information Center 800-994-WOMAN : 4woman.gov.
Pregnant women or women of child-bearing potential Patients with a previous convincing history of hypersensitivity to ribavirin Patients with comorbid illnesses such as hemoglobinopathy e.g., thalassemia or sickle-cell anemia ; , unstable cardiac disease or gout particular caution required ; Patients with renal insufficiency see Box 1 and sodium.
In Stevens v. Tamai, No. 03-1479 May 4, 2004 ; , a unanimous panel of the U.S. Court of Appeals for the Federal Circuit reversed the decision of the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, which had awarded judgment against Sanford, L.P., a unit of Newell Rubbermaid, Inc. Stevens ; , in an interference proceeding involving a hand-held correction tape dispenser. The Federal Circuit held that the Board incorrectly awarded priority of invention to Seed Rubber Company Tamai ; , because Tamai failed to establish a proper claim to the priority benefit of its original Japanese patent application. Carl Moore, Jr., a partner with Marshall, Gerstein & Borun LLP argued for Stevens. , With him on the briefs were MGB partners Sandip Patel, Michael Weiner, and James Zeller. Edward F. Kenehan, Jr., a member of Armstrong, Westerman & Hattori, LLP , argued for Tamai. With him on the brief was Armstrong, Westerman & Hattori member William F. Westerman.
Source: theantidrug The Facts about Marijuana The debate about marijuana continues, but there is one point that everyone generally agrees on - kids should stay away from the drug. Marijuana puts kids at risk. It is the most widely used illicit drug among youth today and is more potent than ever. Do you know the facts about marijuana? If you're a parent, it's the first step toward raising drug-free kids. Usually smoked as a cigarette or joint, or in a pipe or bong, marijuana has appeared in "blunts" in recent years. These are cigars that have been emptied of tobacco and re-filled with marijuana, sometimes in combination with another drug, such as crack. Some users also mix marijuana into foods or use it to brew tea. The main active chemical in marijuana is THC delta-9tetrahydrocannabinol ; . Short-term effects of marijuana use include problems with memory and learning; distorted perception; difficulty in thinking and problemsolving; loss of coordination; and increased heart rate, anxiety, and panic attacks.
Received 15 July 2003; Revised 22 October 2003; Accepted 3 November 2003. Social Inclusion Research Unit, University of Wales NEWI, Plas Coch Campus, Wrexham LL11 2AW, aPsychology Department, Aston University, Birmingham B4 7ET, bLothian NHS Board, Deaconess House, 148 Pleasance, Edinburgh EH8 9RS and cResearch Unit in Health, Behaviour and Change, School of Clinical Sciences and Community Health, College of Veterinary Medicine, The University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK. Correspondence to Dr Julia Lawton; Email: j.Lawton ed.ac.
Pathologic examination. This finding resembles a histologic cure that has been confirmed in cases of chronic hepatitis C for which IFN treatment is markedly effective. The ability of IFN to eradicate HCV and improve liver damage may contribute to the improvement of OLP because histologic improvement of OLP was observed in our cases of OLP with chronic hepatitis C 21 ; . Dalekos et al prospectively evaluated dermatological side-effects during IFN therapy for chronic hepatitis B or C Their study, which was done in northwestern Greece, demonstrated that IFN only rarely 3.3% ; induces immunemediated dermatological disorders, especially LP in patients with chronic viral hepatitis. The authors reported that the development of these disorders may reflect a subclinical or covert autoimmune background of the patients. In our observations of oral lesions made before, during and after IFN treatment, OLP occurred in 16.7% 4 24 patients ; of Japanese subjects 13 ; . Some OLP lesions that appeared during IFN treatment and were aggravated temporarily were improved by symptomatic therapy, so that IFN treatment was continued. Two had OLP before treatment, 1 during treatment and 1 after treatment. Oral leukoplakia was seen in 4 patients before treatment and oral cancer in one patient 6 months after completing treatment 30 ; . In general, it is has been reported that caution should be exercised when IFN therapy is applied to chronic hepatitis C patients with prior OLP manifestations 5 ; . It difficult to predict which HCV cases will show IFN ribavirin-induced OLP or cutaneous LP. However, caution is required in administering IFN or ribavirin to the HCV carriers who already suffer from LP, especially severe OLP of the erosive type. A close inspection of LP is essential before administering antiviral drugs to HCV carrier patients. When oral or cutaneous symptoms are exacerbated during IFN or ribavirin therapy, even if an oral surgeon or a dermatologist treats OLP or.
Ribavirin manufacturers
Relenza .27 Relion 70 30 .9 Relion N .9 Relion R .9 Relpax.6 Remicade .8 Renacidin.29 Renagel.14 Rentamine .36 Reprexain.30 Requip .6 Rescon-Jr.36 Rescriptor .26 Reserpine .19 Respa-1st.36 Respa-PE .36 Respi-Tann.36 Restasis .17 Retin-A liquid .39 Retin-A micro .39 Retrovir .27 Revatio .36 Reyataz .27 Rheumatrex .7 Rhinacon A .36 Rhinocort Aqua .34 Rhinoflex .29 Ribasphere .8 Ribavirin.27 Ridaura .9 Rifamate .26 Rifampin.26 Rilutek.6 Rimantadine .27 Rimso-50.41 Riomet.9 Risperdal.28 Risperdal Consta.28 Ritalin LA .7 Rms-Suppository .30 Robomol 500 .32 Rocephin .24 Roferon-A .8 Rosac .37 Rosaderm.39 Rosula.39 Rosula Ns .39 Roxanol .30 Roxanol-T .30 and requip.
Generic ribavirin
Trocar nome de usuario, spinal tap warmer than hell mp3, coronary artery bypass graft with maze procedure, analgesic products and active immunity occurs when. Ulnar nerve entrapment physical therapy, transverse myelitis mri findings, contraction hypothesis and sweat test cpt or auditory perception center.
Interferon ribavirin dose
Ribavirin order, ribavirin cardiac side effects, ribavirin formulation, ribavirin for sars and peginterferon ribavirin therapy. Rribavirin manufacturers, generic ribavirin, interferon ribavirin dose and ribavirin 100mg or ribavirin more drug_uses.
|
